First Header Logo Second Header Logo

Connection

David Herrington to Clinical Trials as Topic

This is a "connection" page, showing publications David Herrington has written about Clinical Trials as Topic.
Connection Strength

0.529
  1. Yeboah J, Herrington DM. Intermediate end point cardiovascular clinical trials: an excellent idea based on an obsolete paradigm. Expert Rev Cardiovasc Ther. 2014 Feb; 12(2):161-5.
    View in: PubMed
    Score: 0.402
  2. Winkelmann BR, Herrington D. Pharmacogenomics--10 years of progress: a cardiovascular perspective. Pharmacogenomics. 2010 May; 11(5):613-6.
    View in: PubMed
    Score: 0.078
  3. Herrington DM, Howard TD. ER-alpha variants and the cardiovascular effects of hormone replacement therapy. Pharmacogenomics. 2003 May; 4(3):269-77.
    View in: PubMed
    Score: 0.048
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.